ArticleTherapeutic advances in musculoskeletal disease2026
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.
Yu-Hsiu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.